Replies to post #229927 on Biotech Values

[DewDiligence]

FDA approves BMY’s Zeposia for_moderate/severe ulcerative colitis:

https://finance.yahoo.com/news/u-food-drug-administration-approves-201300046.html

Zeposia was approved in 2020 by FDA and EMA for relapsing MS (#msg-154586608, #msg-154614638). The label expansion to UC is BMY’s first GI-immunology approval.